CRMD CORMEDIX INC revenue, earnings and financials

For the quarter ended June 30, 2026, CORMEDIX INC reported revenue of $102M (up 156.5% from a year earlier), net income of $26.0M and diluted EPS of $0.29; over the last four quarters revenue was $462M and net income $187M; for the fiscal year ended December 2025 revenue was $312M, up 617.0% on the year before.

CRMD annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $312M, gross profit $276M, operating income $150M, net income $163M (margin 52.3%), EPS $2.04
• Fiscal year ended Dec 2024: revenue $43.5M, gross profit $40.3M, operating income −$22.4M, net income −$17.9M (margin -41.2%), EPS −$0.30
• Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$49.0M, net income −$46.3M (margin n/a), EPS −$0.91
• Fiscal year ended Dec 2022: revenue $65.4K, gross profit $61.7K, operating income −$30.6M, net income −$29.7M (margin -45409.9%), EPS −$0.74
• Fiscal year ended Dec 2021: revenue $191K, gross profit $42.0K, operating income −$29.4M, net income −$28.2M (margin -14774.7%), EPS −$0.75

CRMD quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $102M (up 156.5% year over year), net income $26.0M, EPS $0.29
• Quarter ended Mar 31, 2026: revenue $127M (up 226.1% year over year), net income $38.6M, EPS $0.43
• Quarter ended Dec 31, 2025 (from the annual report): revenue $129M, net income $14.0M, EPS $0.20
• Quarter ended Sep 30, 2025: revenue $104M (up 810.2% year over year), net income $109M, EPS $1.26
• Quarter ended Jun 30, 2025: revenue $39.7M (up 4829.4% year over year), net income $19.8M, EPS $0.28
• Quarter ended Mar 31, 2025: revenue $39.1M, net income $20.6M, EPS $0.30
• Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income $13.5M, EPS $0.25
• Quarter ended Sep 30, 2024: revenue $11.5M, net income −$2.78M, EPS −$0.05
• Quarter ended Jun 30, 2024: revenue $806K, net income −$14.2M, EPS −$0.25
• Quarter ended Mar 31, 2024: revenue n/a, net income −$14.5M, EPS −$0.25
• Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$14.8M, EPS −$0.25
• Quarter ended Sep 30, 2023: revenue n/a, net income −$9.74M, EPS −$0.17
• Quarter ended Jun 30, 2023: revenue n/a, net income −$11.3M, EPS −$0.25
• Quarter ended Mar 31, 2023: revenue n/a, net income −$10.6M, EPS −$0.24
• Quarter ended Dec 31, 2022 (from the annual report): revenue $29.7K (down 47.3% year over year), net income −$8.21M, EPS −$0.20
• Quarter ended Sep 30, 2022: revenue $6.82K (down 82.1% year over year), net income −$6.85M, EPS −$0.17
• Quarter ended Jun 30, 2022: revenue $21.3K (up 159.5% year over year), net income −$7.60M, EPS −$0.19
• Quarter ended Mar 31, 2022: revenue $7.64K (down 91.3% year over year), net income −$7.03M, EPS −$0.18
• Quarter ended Dec 31, 2021 (from the annual report): revenue $56.4K, net income −$7.79M, EPS −$0.21
• Quarter ended Sep 30, 2021: revenue $38.1K, net income −$8.57M, EPS −$0.22

CRMD cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $175M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$50.6M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$38.4M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$24.4M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$21.2M, share buybacks n/a

CRMD balance sheet

• Jun 30, 2026: cash $257M, total assets $904M, total liabilities $443M, shareholders' equity $461M
• Mar 31, 2026: cash $178M, total assets $816M, total liabilities $379M, shareholders' equity $437M
• Dec 31, 2025: cash $145M, total assets $826M, total liabilities $421M, shareholders' equity $405M
• Sep 30, 2025: cash $48.5M, total assets $751M, total liabilities $377M, shareholders' equity $374M
• Jun 30, 2025: cash $159M, total assets $253M, total liabilities $32.0M, shareholders' equity $221M
• Mar 31, 2025: cash $66.3M, total assets $150M, total liabilities $34.7M, shareholders' equity $115M
• Dec 31, 2024: cash $40.7M, total assets $119M, total liabilities $34.2M, shareholders' equity $84.7M
• Sep 30, 2024: cash $35.3M, total assets $77.6M, total liabilities $18.9M, shareholders' equity $58.7M

What is CRMD's revenue?

CORMEDIX INC reported $462M of revenue over its last four quarters, through June 30, 2026.

Is CRMD profitable?

Yes. CORMEDIX INC earned $187M over the last four quarters.

What is CRMD's EPS?

Diluted earnings per share over the last four quarters were $2.18; $0.29 in the latest quarter.

CRMD ownership and insider trades · All stocks